A Phase 3 Multicenter, Placebo-controlled, Double-blind, Randomized-withdrawal Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis
收藏DataCite Commons2025-12-20 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00004860/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate safety and effectiveness of golimumab in Japanese participants with moderately to severely active ulcerative colitis.
提供机构：
Vivli
创建时间：
2019-09-19
